Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Microbiotechnology

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1565689

This article is part of the Research Topic Harnessing Microbes for Eco-Friendly Nanoparticle Production and Sustainable Applications View all articles

AgNPs biosynthesized from Pseudomonas Z9.3 metabolites as antimicrobial agents against bacterial and fungal pathogens

Provisionally accepted
  • 1 Faculty of Pharmacy, Universidad San Pablo-CEU Universities, Madrid, Spain
  • 2 Institute of Food Biotechnology and Genomics NAS of Ukraine, Kyiv, Ukraine

The final, formatted version of the article will be published soon.

    An eco-friendly method for the biosynthesis of functional silver nanoparticles (AgNPs) using plant growth promoting bacteria (PGPB), in particular Pseudomonas sp. Z9.3, has been developed. The influence of physicochemical parameters (temperature, pH and concentrations of AgNO3) on the synthesis of AgNPs was studied, setting two optimal physicochemical conditions at 37 °C, pH 9, and a 5:1 ratio of bacterial supernatant to 5 mM AgNO3(S1-9) and 37 °C, pH 7, and a 2:4 ratio (S4-7). The formation of AgNPs was confirmed by UV-visible spectroscopy with an absorption range between 400 and 450 nm. The SEM and TEM analysis showed the spherical shape of AgNPs with a good distribution of nanoparticles and the average size ranged from 8.24 ± 0.26 to 13.32 ± 0.4 nm. Antibacterial activity against different pathogenic bacteria and fungi was tested. Antibacterial activity of AgNPs against 6 human pathogens and 3 phytopathogens was evaluated. The antibacterial potential of S1-9 against Gram-negative strains was lower than against Gram-positive strains; in particular, S. epidermidis was the most sensitive (93.76 %) compared to the equivalent concentration of Ag. In the case of fungi, S4-7 exhibited better inhibitory activity compared to the negative control. The highest dose (120 ppm) of S4-7 AgNP inhibited fungal growth being the most sensitive Alternaria sp. (74.97 %), followed by Stemphylium sp. (66.30 %), Fusarium sp. (45.62 %) and Rhizopus sp. (32.68 %).

    Keywords: biosynthesis, beneficial bacteria, silver nanoparticles, pathogens, Antimicrobial activity

    Received: 23 Jan 2025; Accepted: 24 Mar 2025.

    Copyright: © 2025 Plokhovska, Fuente-González, Gutierrez-Albanchez, Gutierrez-Mañero and Ramos-Solano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Svitlana Plokhovska, Faculty of Pharmacy, Universidad San Pablo-CEU Universities, Madrid, Spain
    Beatriz Ramos-Solano, Faculty of Pharmacy, Universidad San Pablo-CEU Universities, Madrid, Spain

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more